ENTROLATE

Main information

Trade name:
ENTROLATE 10 TAB

Active ingredient:
Diloxanide Furoate,Tinidazole

Available from:
Stadmed

Dosage:
500,300;MG

Pharmaceutical form:
TAB

Composition:
10

Medicine domain:
Humans

Medicine type:
Allopathic drug

Documents

for the general public:
The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.

Request the information leaflet for the general public.

for healthcare professionals:
The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.

Request the information leaflet for healthcare professionals.

Localization

Available in:
India

Language:
English

Other information

Status

Source:
Central Drugs Standard Control Organization

Last update:
09-08-2016

The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.

Request the information leaflet for the general public.

Access to this document is only available to registered users.

Register now for full access

30-1-2018

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate / vilanterol, Revision: 13, Authorised

Europe - EMA - European Medicines Agency

30-1-2018

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate / vilanterol, Revision: 11, Authorised

Europe - EMA - European Medicines Agency

26-1-2018

Pending EC decision: Relvar Ellipta, fluticasone furoate / vilanterol, Opinion date: 25-Jan-2018

Europe - EMA - European Medicines Agency

26-1-2018

Pending EC decision: Revinty Ellipta, fluticasone furoate / vilanterol, Opinion date: 25-Jan-2018

Europe - EMA - European Medicines Agency

25-1-2018

Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate / umeclidinium / vilanterol, Revision: 0, Authorised

Europe - EMA - European Medicines Agency

12-1-2018

Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate / umeclidinium / vilanterol, Revision: 0, Authorised

Europe - EMA - European Medicines Agency

27-9-2017

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate / vilanterol, Revision: 11, Authorised

Europe - EMA - European Medicines Agency

26-9-2017

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate / vilanterol, Revision: 9, Authorised

Europe - EMA - European Medicines Agency

15-9-2017

Pending EC decision: Trelegy Ellipta, fluticasone furoate / umeclidinium / vilanterol, Opinion date: 14-Sep-2017

Europe - EMA - European Medicines Agency

15-9-2017

Pending EC decision: Elebrato Ellipta, fluticasone furoate / umeclidinium / vilanterol , Opinion date: 14-Sep-2017

Europe - EMA - European Medicines Agency

4-9-2017

Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Revision: 17, Authorised

Europe - EMA - European Medicines Agency

17-8-2017

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate / vilanterol, Revision: 10, Authorised

Europe - EMA - European Medicines Agency

25-7-2017

Opinion/decision on a Paediatric investigation plan (PIP): -, Indacaterol (acetate) / mometasone (furoate), Therapeutic area: Pneumology-allergology

Europe - EFSA - European Food Safety Authority EFSA Journal

25-7-2017

Opinion/decision on a Paediatric investigation plan (PIP): Relvar Ellipta and associated names, Fluticasone (furoate) / vilanterol, Therapeutic area: Pneumology-allergology

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2017

Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Revision: 16, Authorised

Europe - EMA - European Medicines Agency

29-6-2017

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate / vilanterol, Revision: 8, Authorised

Europe - EMA - European Medicines Agency

6-4-2018

ASMANEX (Mometasone Furoate) Inhalant [Merck Sharp Dohme Corp.]

Updated Date: Apr 6, 2018 EST

US - DailyMed

6-4-2018

ASMANEX HFA (Mometasone Furoate) Aerosol [Merck Sharp Dohme Corp.]

Updated Date: Apr 6, 2018 EST

US - DailyMed

5-4-2018

Asmanex Twisthaler (Mometasone Furoate Inhalation Powder) - new on RxList

US - RxList

5-4-2018

Dulera (Mometasone Furoate, Formoterol Fumarate Dihydrate Inhalation) - updated on RxList

US - RxList

22-3-2018

MOMETASONE FUROATE Spray, Metered [REMEDYREPACK INC.]

Updated Date: Mar 22, 2018 EST

US - DailyMed

20-2-2018

Flagyl vs. Tindamax

Flagyl, Flagyl ER, and Flagyl Injection (metronidazole) and Tindamax (tinidazole) are nitroimidazole antibiotics used to treat bacterial infections. Side effects of Flagyl and Tindamax that are similar include nausea, vomiting, stomach upset, stomach/abdominal cramps/pain, diarrhea, constipation, dizziness, headache, or a bitter or metallic taste in the mouth or changes in taste.

US - RxList

1-2-2018

SINUVA (Mometasone Furoate) Implant [Intersect ENT, Inc.]

Updated Date: Feb 1, 2018 EST

US - DailyMed

22-1-2018

MOMETASONE FUROATE Cream [A-S Medication Solutions]

Updated Date: Jan 22, 2018 EST

US - DailyMed

16-1-2018

DULERA (Mometasone Furoate And Formoterol Fumarate Dihydrate) Aerosol [A-S Medication Solutions]

Updated Date: Jan 16, 2018 EST

US - DailyMed

8-1-2018

BREO ELLIPTA (Fluticasone Furoate And Vilanterol Trifenatate) Powder [GlaxoSmithKline LLC]

Updated Date: Jan 8, 2018 EST

US - DailyMed

8-1-2018

BREO ELLIPTA (Fluticasone Furoate And Vilanterol Trifenatate) Powder [Glaxo Operations UK Ltd]

Updated Date: Jan 8, 2018 EST

US - DailyMed

2-1-2018

MOMETASONE FUROATE Ointment [A-S Medication Solutions]

Updated Date: Jan 2, 2018 EST

US - DailyMed

29-12-2017

MOMETASONE FUROATE Spray, Metered [Golden State Medical Supply, Inc.]

Updated Date: Dec 29, 2017 EST

US - DailyMed

21-12-2017

Sinuva (Mometasone Furoate) - new on RxList

US - RxList

20-12-2017

NASONEX (Mometasone Furoate Monohydrate) Spray, Metered [Merck Sharp Dohme Corp.]

Updated Date: Dec 20, 2017 EST

US - DailyMed

13-12-2017

TINDAZOLE (Tinidazole) Tablet, Film Coated [Rising Pharmaceuticals, Inc.]

Updated Date: Dec 13, 2017 EST

US - DailyMed

8-12-2017

Flovent Diskus vs. Asmanex

Flovent (fluticasone propionate) and Asmanex HFA (mometasone furoate) are steroids used to prevent asthma attacks.

US - RxList

5-12-2017

Flovent vs. Asmanex

Flovent (fluticasone propionate) and Asmanex HFA (mometasone furoate) are steroids used to prevent asthma attacks.

US - RxList

22-11-2017

MOMETASONE FUROATE Cream [Harris Pharmaceutical, Inc.]

Updated Date: Nov 22, 2017 EST

US - DailyMed

17-11-2017

Elebrato Ellipta (GlaxoSmithKline Trading Services Limited)

Elebrato Ellipta (Active substance: fluticasone furoate/umeclidinium/vilanterol) - Centralised - Authorisation - Commission Decision (2017)7745 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4781

Europe -DG Health and Food Safety

17-11-2017

Trelegy Ellipta (GlaxoSmithKline Trading Services Limited)

Trelegy Ellipta (Active substance: fluticasone furoate/umeclidinium/vilanterol) - Centralised - Authorisation - Commission Decision (2017)7744 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4363

Europe -DG Health and Food Safety

25-10-2017

MOMETAMAX (Gentamicin Sulfate, Mometasone Furoate Monohydrate, And Clotrimazole) Suspension [Merck Sharp Dohme Corp.]

Updated Date: Oct 25, 2017 EST

US - DailyMed

25-10-2017

MOTAZOL (Gentamicin Sulfate, Mometasone Furoate Monohydrate, And Clotrimazole) Suspension [MWI]

Updated Date: Oct 25, 2017 EST

US - DailyMed

23-10-2017

MOMETASONE FUROATE Ointment [Perrigo New York Inc]

Updated Date: Oct 23, 2017 EST

US - DailyMed

18-10-2017

TINIDAZOLE Tablet [Lupin Pharmaceuticals,Inc.]

Updated Date: Oct 18, 2017 EST

US - DailyMed

28-9-2017

Trelegy Ellipta (Fluticasone Furoate Inhalation Powder) - new on RxList

US - RxList

25-9-2017

Revinty Ellipta (Glaxo Group Ltd)

Revinty Ellipta (Active substance: fluticasone furoate / vilanterol trifenatate) - Centralised - Yearly update - Commission Decision (2017)6510 of Mon, 25 Sep 2017

Europe -DG Health and Food Safety

25-9-2017

Relvar Ellipta (Glaxo Group Ltd)

Relvar Ellipta (Active substance: fluticasone furoate/vilanterol trifenatate) - Centralised - Yearly update - Commission Decision (2017)6508 of Mon, 25 Sep 2017

Europe -DG Health and Food Safety

20-9-2017

FDA Approves Trelegy Ellipta for COPD

The US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with chronic obstructive pulmonary disease (COPD).

US - RxList

19-9-2017